– voice AI platform
Theme is clear:
AI • Energy • Aerospace • Automation • Infrastructure
Capital is rotating into the future — and these are the companies building it.
Stay early. Stay positioned.
$CLPT just dropped their Q4 2025 results. The stock is down 5%.
They hit record sales of $37 million, marking their 11th straight year of growth. Their core business of helping surgeons navigate the brain is thriving, and their recent IRRAS acquisition gives them even more tools.
On the other side, their financial losses widened to $25.5 million because they are spending heavily to integrate the new business, develop technology, and hire more staff.
$CLPT to report earnings tonight.
I find them a fun company to follow. They sit at the cutting edge of brain surgery. They mix robotics and navigation to help deliver drugs directly into the brain for complex neurological diseases.
Beyond the standard revenue and profit numbers, here is what I’ll be keeping a close eye on:
- New partnerships for their drug delivery systems.
- Hospital adoption: Are more operating rooms installing their tech?
- The success of their new PRISM laser therapy.
- Trial updates: Progress on clinical trials from their pharma partners.
$CLPT higher on $QURE results. ClearPoint sells the imaging equipment that allows the precise surgical implantation of the gene therapy into the brain.
